Grapefruit Juice and Statins

This publication has 18 references indexed in Scilit:

• Drug-grapefruit juice interactions
  BMJ, 2013
• Grapefruit–medication interactions: Forbidden fruit or avoidable consequences?
  Canadian Medical Association Journal, 2012
• Rhabdomyolysis Associated With Pomegranate Juice Consumption
  The American Journal of Cardiology, 2006
• A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice–felodipine interaction
  The American Journal of Clinical Nutrition, 2006
• Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin
  British Journal of Clinical Pharmacology, 2005
• Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance
  European Journal of Clinical Nutrition, 2003
• Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
  Clinical Pharmacology & Therapeutics, 1999
• Grapefruit juice—simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors*
  Clinical Pharmacology & Therapeutics, 1998
• Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
  Chemical Research in Toxicology, 1998
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
  Journal of Clinical Investigation, 1997